If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "IcoMetrix"
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| + | [[Category:LinkedIn Accounts]] | ||
| + | [[Category:Twitter Accounts]] | ||
| + | [[Category:GitHub Accounts]] | ||
| + | [[Category:Facebook Pages]] | ||
| + | [[Category:YouTube Channels]] | ||
[[Category:Organizations]] | [[Category:Organizations]] | ||
[[Category:Companies]] | [[Category:Companies]] | ||
| − | icometrix provides clinicians with standardized measurements on their patients | + | "icometrix provides clinicians with standardized measurements on their patients' brain MRI scans in order to improve personalized care of people with a neurological disorder. |
icometrix was founded in 2011 by Dirk Loeckx and Wim Van Hecke. It is a spin-off company of the universities and university hospitals of Leuven and Antwerp. Today, icometrix has grown to a team of over 25 people and is internationally active, with headquarters in Leuven and an office in Boston, USA. They are the worldwide standard in MRI biomarkers in routine clinical practice. | icometrix was founded in 2011 by Dirk Loeckx and Wim Van Hecke. It is a spin-off company of the universities and university hospitals of Leuven and Antwerp. Today, icometrix has grown to a team of over 25 people and is internationally active, with headquarters in Leuven and an office in Boston, USA. They are the worldwide standard in MRI biomarkers in routine clinical practice. | ||
| Line 7: | Line 12: | ||
icometrix developed MSmetrix, which detects brain lesions, calculates lesion volume and measures the whole brain and grey matter volume and atrophy. MSmetrix, received market approval in the EU and other countries including Canada, Brazil and Australia. FDA clearance is pending. Furthermore, icometrix is ISO9001 and ISO13485 (Medical Devices) and ISO27001 (Information Security) certified. | icometrix developed MSmetrix, which detects brain lesions, calculates lesion volume and measures the whole brain and grey matter volume and atrophy. MSmetrix, received market approval in the EU and other countries including Canada, Brazil and Australia. FDA clearance is pending. Furthermore, icometrix is ISO9001 and ISO13485 (Medical Devices) and ISO27001 (Information Security) certified. | ||
| − | icometrix also acts as an image analysis expert in clinical trials and research studies. Imaging biomarkers constantly lead to new insights on neurological disorders. Since recently, imaging biomarker outcomes often serve as the primary endpoints in clinical trials for the development of new drugs. For these purposes large batches of brain imaging data are frequently transferred to icometrix for fast and high quality processing. This way our software-as-a-service is incorporated in clinical trials and large research studies regarding Traumatic Brain Injury (TBI), Epilepsy, Alzheimer | + | icometrix also acts as an image analysis expert in clinical trials and research studies. Imaging biomarkers constantly lead to new insights on neurological disorders. Since recently, imaging biomarker outcomes often serve as the primary endpoints in clinical trials for the development of new drugs. For these purposes large batches of brain imaging data are frequently transferred to icometrix for fast and high quality processing. This way our software-as-a-service is incorporated in clinical trials and large research studies regarding Traumatic Brain Injury (TBI), Epilepsy, Alzheimer's Disease, Stroke, etc." |
| Line 13: | Line 18: | ||
Founded in Belgium around 2011, IcoMetrix produces end-user software. | Founded in Belgium around 2011, IcoMetrix produces end-user software. | ||
| − | IcoMetrix makes tools for medical diagnosis and treatment through body/mind state interpretation and neurostimulation therapies. | + | IcoMetrix makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies. |
[[Brain Computer Interface Classification|BCI Categories]]: Open-Loop Efferent | [[Brain Computer Interface Classification|BCI Categories]]: Open-Loop Efferent | ||
| Line 23: | Line 28: | ||
[https://www.linkedin.com/company/icometrix/ LinkedIn] | [https://www.linkedin.com/company/icometrix/ LinkedIn] | ||
[https://github.com/icometrix GitHub] | [https://github.com/icometrix GitHub] | ||
| + | [https://twitter.com/icometrix Twitter] | ||
| + | [https://www.youtube.com/user/icoMetrix YouTube] | ||
| + | [https://www.facebook.com/icometrix Facebook] | ||
Latest revision as of 13:26, 13 June 2022
"icometrix provides clinicians with standardized measurements on their patients' brain MRI scans in order to improve personalized care of people with a neurological disorder.
icometrix was founded in 2011 by Dirk Loeckx and Wim Van Hecke. It is a spin-off company of the universities and university hospitals of Leuven and Antwerp. Today, icometrix has grown to a team of over 25 people and is internationally active, with headquarters in Leuven and an office in Boston, USA. They are the worldwide standard in MRI biomarkers in routine clinical practice.
icometrix developed MSmetrix, which detects brain lesions, calculates lesion volume and measures the whole brain and grey matter volume and atrophy. MSmetrix, received market approval in the EU and other countries including Canada, Brazil and Australia. FDA clearance is pending. Furthermore, icometrix is ISO9001 and ISO13485 (Medical Devices) and ISO27001 (Information Security) certified.
icometrix also acts as an image analysis expert in clinical trials and research studies. Imaging biomarkers constantly lead to new insights on neurological disorders. Since recently, imaging biomarker outcomes often serve as the primary endpoints in clinical trials for the development of new drugs. For these purposes large batches of brain imaging data are frequently transferred to icometrix for fast and high quality processing. This way our software-as-a-service is incorporated in clinical trials and large research studies regarding Traumatic Brain Injury (TBI), Epilepsy, Alzheimer's Disease, Stroke, etc."
Founded in Belgium around 2011, IcoMetrix produces end-user software.
IcoMetrix makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.
BCI Categories: Open-Loop Efferent
Neurosensing Technique(s): MRI